Tadan's Touch Foundation in Tipton, IA - Counselor

Tadan's Touch Foundation is a mental health clinic (Counselor - Mental Health) in Tipton, Iowa. The current practice location for Tadan's Touch Foundation is 46 Spruce St., Suite 1 & 2, Tipton, Iowa. For appointments, you can reach them via phone at (563) 349-8038. The mailing address for Tadan's Touch Foundation is 100 Plum St, Tipton, Iowa and phone number is (563) 349-8038.

Tadan's Touch Foundation is licensed to practice in * (Not Available) (license number ) and its NPI number is 1215682000. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (563) 349-8038.

Contact Information

	Tadan's Touch Foundation
	46 Spruce St. Suite 1 & 2 Tipton IA 52772-5277
	(563) 349-8038
	(563) 886-8016

Mental Health Clinic Profile

Full Name	Tadan's Touch Foundation
Speciality	Counselor - Mental Health
Location	46 Spruce St., Tipton, Iowa
Authorized Official Name and Position	Todd Andrew Foss (PRESIDENT)
Authorized Official Contact	5633498038
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Tadan's Touch Foundation 100 Plum St Tipton IA 52772-1914 Ph: (563) 349-8038	Tadan's Touch Foundation 46 Spruce St. Suite 1 & 2 Tipton IA 52772-5277 Ph: (563) 349-8038

NPI Details:

NPI Number	1215682000
Provider Enumeration Date	02/20/2022
Last Update Date	11/14/2022
Certification Date	11/14/2022

Medical Identifiers

Medical identifiers for Tadan's Touch Foundation such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215682000	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	(* (Not Available))	Primary

News Archive

Treatment commences in NeuroVive-HCL's 1,000 patient European cardioprotection trial

NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.

Medtronic launches Achieve Mapping Catheter in Europe

Medtronic, Inc. today announced the European launch of the Achieve Mapping Catheter, an intra-cardiac electrophysiology recording catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.

Researchers identify commensal bacteria in the human intestine

Researchers at Baylor College of Medicine and Texas Children's Hospital have identified commensal bacteria in the human intestine that produce a neurotransmitter that may play a role in preventing or treating inflammatory bowel diseases such as Crohn's disease.

Southern African health officials develop cross-border initiative for malaria elimination

Health ministers from eight countries in the Southern African Development Community this week held a Malaria Elimination Ministerial Meeting in the Namibian capital of Windhoek to develop a cross-border approach for eliminating malaria in the region, New Era reports.

Tadan's Touch Foundation - Mental Health Clinic in Tipton, IA